Main Menu

New initiatives to cure diseases of the poor world, The Economist

The Economist,  July 16, 2009

HEALTH-CARE activists have long maintained that the system for granting patents on drugs denies the poor access to essential medicines and discourages pharmaceutical firms from collaborating to develop new ones for neglected diseases. Several initiatives announced this week, some focused on collaboration and others on openness, may help to remedy those problems.

Read the full article in The Economist:
http://www.economist.com/businessfinance/displaystory.cfm?story_id=14031424